Jain PharmaBiotech

Jain PharmaBiotech was formed by Prof. Dr. K. K. Jain in 1996 for basic as well as clinical research and to provide consulting services for the biopharmaceutical industries. Their key expertise lie in neurology, cancer, personalized medicine, cell therapy, gene therapy, RNA interference, Proteomics, Molecular diagnostics, biomarkers, nanobiotechnology, drug delivery technologies. Jain PharmaBiotech also carries lecturing activities.

Results 1 - 20 of 20

previous 1 next

Title	Date	Price
Drug Delivery to Central Nervous System Diseases Technologies, Markets and Companies	Oct 2009	£1,505
Drug Delivery in Cancer Technologies, Markets and Companies	Oct 2009	£2,105
Nitric oxide Therapeutics, Markets and Companies	Oct 2009	£1,685
RNAi Technologies, Markets and Companies	Oct 2009	£1,805
Cardiovascular Drug Delivery Technologies, Markets and Companies	Oct 2009	£1,505
Proteomics Technologies, Markets and Companies	Oct 2009	£2,405
Neuroprotection Drugs, Markets and Companies	Oct 2009	£2,405
Antiviral Therapeutics Technologies, Markets and Companies	Oct 2009	£1,805
Pain Therapeutics Drugs, Markets and Companies	Oct 2009	£1,805
Cell therapy Technologies, Markets and Companies	Oct 2009	£2,705
Animal Biotechnology Technologies, Markets and Companies	Oct 2009	£1,505
Molecular Diagnostics Technologies, Markets and Companies	Oct 2009	£2,705
Cytogenetics Technologies, Markets and Companies	Oct 2009	£1,200
Biomarkers Technologies, Markets and Companies	Oct 2009	£2,405
Personalized Medicine Scientific & Commercial Aspects	Oct 2009	£2,405
Transdermal Drug Delivery Technologies, Markets and Companies	Oct 2009	£1,505
Nanobiotechnology Applications, Markets and Companies	Oct 2009	£2,405
Gene Therapy Technologies, Markets and Companies	Oct 2009	£2,405
Alzheimer's Disease New Drugs, Markets and Companies	Oct 2009	£1,805
DNA sequencing Technologies, Markets and Companies	Oct 2009	£900